Jan 14, 2014
1:50
For every 50 shares held, investors received 1. The price per share adjusted from $0.10 to $0.00.
The split itself did not change the total investment value.
La Jolla Pharmaceutical Company (LJPC) trades on the NASDAQ Capital Market in the Biotechnology industry.
La Jolla Pharmaceutical Company company overviewThe latest split shown was on January 14, 2014. It was a 1-for-50 reverse split, so shareholders received 1 share for every 50 they held.
This history records one reverse split, on January 14, 2014.